These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 26930407)
21. A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers. Evers SS; van Vliet A; van Vugt B; Scheurink AJ; van Dijk G Psychoneuroendocrinology; 2016 Apr; 66():101-10. PubMed ID: 26802597 [TBL] [Abstract][Full Text] [Related]
22. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. Ujike H; Nomura A; Morita Y; Morio A; Okahisa Y; Kotaka T; Kodama M; Ishihara T; Kuroda S J Clin Psychiatry; 2008 Sep; 69(9):1416-22. PubMed ID: 19193342 [TBL] [Abstract][Full Text] [Related]
23. Orally disintegrating olanzapine induces less weight gain in adolescents than standard oral tablets. Crocq MA; Guillon MS; Bailey PE; Provost D Eur Psychiatry; 2007 Oct; 22(7):453-4. PubMed ID: 17761403 [TBL] [Abstract][Full Text] [Related]
24. Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions. Birkenaes AB; Birkeland KI; Friis S; Opjordsmoen S; Andreassen OA J Clin Psychopharmacol; 2009 Apr; 29(2):109-16. PubMed ID: 19512971 [TBL] [Abstract][Full Text] [Related]
25. Association of olanzapine-induced weight gain with an increase in body fat. Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009 [TBL] [Abstract][Full Text] [Related]
26. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents. Melkersson KI; Hulting AL Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683 [TBL] [Abstract][Full Text] [Related]
28. Amantadine for weight gain associated with olanzapine treatment. Deberdt W; Winokur A; Cavazzoni PA; Trzaskoma QN; Carlson CD; Bymaster FP; Wiener K; Floris M; Breier A Eur Neuropsychopharmacol; 2005 Jan; 15(1):13-21. PubMed ID: 15572269 [TBL] [Abstract][Full Text] [Related]
29. Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine. Kim BJ; Sohn JW; Park CS; Hahn GH; Koo J; Noh YD; Lee CS J Korean Med Sci; 2008 Aug; 23(4):685-90. PubMed ID: 18756058 [TBL] [Abstract][Full Text] [Related]
30. Trajectories of agouti-related protein and leptin levels during antipsychotic-associated weight gain in patients with schizophrenia. Ehrlich S; Leopold K; Merle JV; Theophil I; Haag W; Lautenschlager M; Schaefer M J Clin Psychopharmacol; 2012 Dec; 32(6):767-72. PubMed ID: 23131879 [TBL] [Abstract][Full Text] [Related]
31. Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia. Klemettilä JP; Kampman O; Seppälä N; Viikki M; Hämäläinen M; Moilanen E; Mononen N; Lehtimäki T; Leinonen E Eur Psychiatry; 2015 Feb; 30(2):296-302. PubMed ID: 25284335 [TBL] [Abstract][Full Text] [Related]
32. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone. Lee SY; Park MH; Patkar AA; Pae CU Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575 [TBL] [Abstract][Full Text] [Related]
33. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study. Baeza I; Vigo L; de la Serna E; Calvo-Escalona R; Merchán-Naranjo J; Rodríguez-Latorre P; Arango C; Castro-Fornieles J Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):35-46. PubMed ID: 27209421 [TBL] [Abstract][Full Text] [Related]
34. Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia. Suzuki Y; Ono S; Sugai T; Fukui N; Watanabe J; Tsuneyama N; Sawamura K; Someya T Hum Psychopharmacol; 2011 Aug; 26(6):440-3. PubMed ID: 21823168 [TBL] [Abstract][Full Text] [Related]
35. Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study. Kahn RS; Kane JM; Correll CU; Arevalo C; Simmons A; Graham C; Yagoda S; Hu B; McDonnell D J Clin Psychiatry; 2023 Mar; 84(3):. PubMed ID: 36946605 [No Abstract] [Full Text] [Related]
36. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study. Wampers M; Hanssens L; van Winkel R; Heald A; Collette J; Peuskens J; Reginster JY; Scheen A; De Hert M Eur Neuropsychopharmacol; 2012 Jan; 22(1):17-26. PubMed ID: 21511441 [TBL] [Abstract][Full Text] [Related]
37. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. Melkersson KI; Hulting AL; Brismar KE J Clin Psychiatry; 2000 Oct; 61(10):742-9. PubMed ID: 11078035 [TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers. Silverman BL; Martin W; Memisoglu A; DiPetrillo L; Correll CU; Kane JM Schizophr Res; 2018 May; 195():245-251. PubMed ID: 29158012 [TBL] [Abstract][Full Text] [Related]